Brief: Syngene International Acquires First Biologics Site In USA
March 10 (Reuters) - Syngene International Ltd SYNN.NS: SYNGENE INTERNATIONAL LTD - ACQUIRES FIRST BIOLOGICS SITE IN USA SYNGENE INTERNATIONAL LTD - NEW SITE INCREASES BIOREACTOR CAPACITY TO 50,000L SYNGENE INTERNATIONAL LTD - INVESTMENT IN US FACILITY ESTIMATED AT $50 MILLION Source text: [ID:] Further company coverage: SYNN.NS ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Syngene International
See all newsIndia's Syngene advances after quarterly profit rebound
Brief: Syngene International Sept-Quarter Consol Profit 322 Million Rupees
India's Syngene International slides to 6-year low on Q1 loss, full-year forecast
Brief: Syngene International Posts June-Quarter Consol Loss 90 Million Rupees
Brief: Syngene International Says Granted Tax Refund Of 86.2 Million Rupees